Celebrating a successful 2026 International HBV Meeting in Singapore

We are thrilled to reflect on the success of the 2026 International HBV Meeting, coordinated by the Hepatitis B Foundation and held from Sept. 6–10 in Singapore. The conference convened leading global minds for an exchange of research and strategies targeting hepatitis B and D viruses.

The Emerging Researchers Workshop


Our Foundation led a workshop dedicated to supporting the next generation of scientific leaders; this trainee workshop provided graduate students and postdoctoral fellows with invaluable mentorship, career-stage networking, and platforms to present their cutting-edge work.


The 7th Annual Community Forum


Bridging the gap between scientific discovery and lived experience, these sessions brought together affected community members, clinicians, and scientists to ensure that patient perspectives directly inform ongoing research and cure-focused initiatives.

*Recording coming soon.

Thank you to the co-organizers, keynote speakers, awardees, and all attendees who made this year's event an unforgettable milestone for the global HBV community!

Join us for the FREE B Informed Liver Cancer Conference

We invite you to join us for the upcoming B Informed Liver Cancer Conference, a virtual educational event dedicated to advancing discussions on hepatocellular carcinoma (HCC) detection, care, and lived experiences.

Tuesday, Oct. 27, 2026

12:00 – 4:00 p.m. EDT

Virtual Event

Conference Highlights



  • Expert Presentations: Deep dive into crucial topics including hepatocellular carcinoma (HCC) surveillance, early detection, modern diagnostic testing, and advanced treatment options.
  • Lived Experience Panel: Hear perspectives from liver cancer survivors and individuals at risk.
  • Expert Panel Discussion: Gain insights from specialists on best practices for effective HCC surveillance and testing.
  • Interactive Q&A: Bring your questions to our presenting medical experts.

Real Stories with a Real Impact: #justB Storytellers

Through the #justB campaign, advocates like DeWayne, Trieu, and Alan stepped forward to share their journeys on the Voices for Vaccines Blog.

DeWayne: Felt completely fine before his diagnosis, reminding us that feeling healthy isn't the same as being protected.

Trieu: Shared an intimate look at navigating life with a chronic diagnosis, emphasizing why proactive testing and awareness matters.

Alan: Used his voice to break down persistent stigmas and champion routine vaccination to protect future generations.

Read their full experiences on the Voices for Vaccines Blog.

Hepatitis B Foundation showcases at COLDA

We are excited to share key updates from the recent conference, where the Hepatitis B Foundation and the African Hepatitis B Advocacy Coalition (ABAC) showcased vital research, community-led initiatives, and collaborative partnerships driving real-world impact across the continent.

Community-Led Impact: Our poster, “Advancing Hepatitis B Elimination through Community-Led Advocacy: 2025 Outcomes from the African Hepatitis B Advocacy Coalition Community Grants”, highlighted grassroots awareness, screening, vaccination, linkage to care, provider training, and policy advocacy across Nigeria, Tanzania, Uganda, and Mali.


Patient-Reported Outcomes: Findings from the multinational B-PROACTive study were presented in “Patient-Reported Outcomes, Treatment Status, and Barriers to Hepatitis B Care among Adults in Africa.” This work examined quality of life, medication adherence, and systemic barriers, and was featured in the conference's guided poster tour. [poster coming soon]


Broad Continental Collaboration: ABAC staff also co-authored implementation and qualitative research alongside partners—including studies with the University Clinical Research Center in Bamako, Mali, Addis Ababa University in Ethiopia, and the Waklisa Development Association in the Afar region.

Faculty Spotlight: Expert leadership in hepatitis B care

We are thrilled to highlight our esteemed colleagues, Dr. Su Wang and Dr. Yasmin Ibrahim, who are serving as expert faculty for the upcoming live symposium, Paving the Way to Functional Cure: Integrating Therapeutic Advances and Latest Guidelines Into Care for People Living With Hepatitis B.

Event Details


Saturday, Nov. 7, 2026

12:30 p.m. MST


Colorado Convention Center Four Seasons Ballrooms 2/3 Denver, Colorado


Virtual livestream options available.

Join us in celebrating their leadership in advancing global hepatitis B education and care!

Dr. Yasmin Ibrahim joins as a Speaker. She is the Senior Public Health Program Director at the Hepatitis B Foundation and Associate Professor of Public Health at the Baruch S. Blumberg Institute.

Dr. Su Wang serves as Course Director and Speaker. She is the Senior Advisor for Global Health with the Hepatitis B Foundation and Medical Director of Viral Hepatitis Programs and RWJBH Medical Group.

Support the 2026 TCS New York City Marathon #Run4HepB Team

The Hepatitis B Foundation is an Official Charity Partner for the 2026 TCS New York City Marathon, which has become one of our best means for raising funds to support the fight against hepatitis B.

Please join us in cheering on the #Run4HepB Team who are running to make every step count:

  • Aaron Rak
  • Bharat Dixit
  • Callum Clifford
  • Emma Thomson
  • Jennifer Banz
  • Juliana Kugelmas
  • Lou Kassa
  • Ryan DiLeva

Share your story: Join the Foundation's storytelling project

Your story has the power to change the world.


The Hepatitis B Foundation is looking for new storytellers to participate in our upcoming storytelling project workshop. This workshop is designed to bring together individuals living with or affected by hepatitis B to learn how to effectively share their personal journeys. Learn how to: Educate the public, raise awareness and inspire policy change.


To learn about this project and submit your application, visit our website here.

Help us improve hepatitis B care & treatment access in Africa

The African Hepatitis B Advocacy Coalition (ABAC), a program of the Hepatitis B Foundation, is launching a crucial survey to better understand the current landscape of hepatitis B care, challenges in accessing treatment, and areas where we can make a real difference. This will inform global and national strategies to improve equitable access to treatment.

The survey is available in English and French.

Share your voice on the Foundation's quality-of-life survey

The Hepatitis B Foundation is seeking participants for a new research study titled HepB PROACTive (Hepatitis B: Patient-Reported Outcomes, Adherence and Quality-of-Life Tracking).


The goal of this program is to better understand the daily experiences, treatment challenges and overall well-being of individuals living with chronic hepatitis B. We're seeking adults age 18+ with hepatitis B living anywhere in the world.

Participants may also complete the survey in

Traditional Chinese (繁體中) or Simplified Chinese (简体中文).

New podcast: Increasing representation in hepatitis B clinical research

[L-R] Fiona Borondy-Jenkins, MPH, Public Health Program Coordinator and Shreya Koirala, MPH, Public Health Program Manager with the Hepatitis B Foundation

In this episode, we sit down with Fiona Borondy-Jenkins and Shreya Koirala from the Hepatitis B Foundation to discuss their new paper: Boosting Diverse Communities’ Participation in Clinical Trials: What People Living with Hepatitis B Must Know.


Key takeaways:

  • The critical importance of diverse representation in research.
  • Common barriers that prevent participation in clinical trials.
  • Practical steps to help individuals make informed decisions about research opportunities.

New Approach to liver cancer treatment proposed by experts

The BEACON-HCC framework, recently published in Hepatology, provides a new approach to hepatocellular carcinoma (HCC) treatment implementation that incorporates tumor burden, a better understanding of tumor biology, and the most recent advances in the therapeutic landscape. BEACON-HCC places a greater emphasis on curative treatment when possible, both at initial presentation and during follow-up, and personalized care for patients with HCC. Developed by a multi-disciplinary panel of 20 North American experts, the new framework aligns closely with independent expert recommendations. The authors anticipate further validation and refinements over time to continue incorporating cutting-edge data for emerging treatment options.

Upcoming Events

Oct. 6, 2026 | 1:30 p.m. EDT

Webinar: HBU Mini Grants Panel Discussion | Register here.

Oct. 23, 2026 | 1 p.m. EDT

Webinar: MASH/MASLD at a Tipping Point

Register here.

Oct. 27, 2026 | 12 - 4 p.m. EDT

B Informed Liver Cancer Conference

Virtual Event | Register here.

Nov. 1, 2026

#Run4HepB Team in the NYC Marathon

Nov. 12, 2026 | 11 a.m. EDT

Bruce Witte Lecture | Register here.

Journal article of the month

Ibrahim, Y., Machado, T., Borondy-Jenkins, F., Koirala, S., Dong, M., Tham, E., Sankare, I., Ali, M., Hua, D., Che, A., & Cohen, C. (2026). Factors affecting willingness to participate in hepatitis B clinical trials among diverse United States populations: Mitigating missed opportunities. Global Health Journal, 10(2), 161-168. https://doi.org/10.1016/j.glohj.2026.06.003


While diverse participation in hepatitis B clinical trials is vital for evaluating new therapies, minority populations remain significantly underrepresented due to barriers like a lack of awareness and poor communication. To address this, a recent study investigated the specific factors influencing the willingness of Asian, African, and Pacific Islander communities living with hepatitis B to participate in clinical research.

The Hepatitis B Foundation is a nonprofit organization working around the world to improve the lives of those affected by hepatitis B, hepatitis D and liver cancer; drive prevention, diagnosis and treatment and accelerate scientific research to achieve cures.

Learn more about our research and education programs at www.hepb.org

Facebook  Twitter  Instagram  Youtube